Brey RL - Search Results

1

Antiphospholipid Antibodies and Recurrent Thrombotic Events: Persistence and Portfolio.

Amory CF, Levine SR, Brey RL, Gebregziabher M, Tuhrim S, Tilley BC, Simpson AC, Sacco RL, Mohr JP; APASS-WARSS Collaborators. Amory CF, et al. Among authors: brey rl. Cerebrovasc Dis. 2015;40(5-6):293-300. doi: 10.1159/000441362. Epub 2015 Oct 29. Cerebrovasc Dis. 2015. PMID: 26513489 Free PMC article. Clinical Trial.

2

Patent foramen ovale, cardiac valve thickening, and antiphospholipid antibodies as risk factors for subsequent vascular events: the PICSS-APASS study.

Rajamani K, Chaturvedi S, Jin Z, Homma S, Brey RL, Tilley BC, Sacco RL, Thompson JL, Mohr JP, Levine SR; PICSS-APASS Investigators. Rajamani K, et al. Among authors: brey rl. Stroke. 2009 Jul;40(7):2337-42. doi: 10.1161/STROKEAHA.108.539171. Epub 2009 Jun 4. Stroke. 2009. PMID: 19498198 Free PMC article.

3

Neurological aspects of antiphospholipid antibody syndrome.

Levine SR, Brey RL. Levine SR, et al. Among authors: brey rl. Lupus. 1996 Oct;5(5):347-53. doi: 10.1177/096120339600500503. Lupus. 1996. PMID: 8902759 Review.

4

Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke.

Levine SR, Brey RL, Tilley BC, Thompson JL, Sacco RL, Sciacca RR, Murphy A, Lu Y, Costigan TM, Rhine C, Levin B, Triplett DA, Mohr JP; APASS Investigators. Levine SR, et al. Among authors: brey rl. JAMA. 2004 Feb 4;291(5):576-84. doi: 10.1001/jama.291.5.576. JAMA. 2004. PMID: 14762036 Free article. Clinical Trial.

5

Relation of antiphospholipid antibodies to postmortem brain infarcts in older people.

Arvanitakis Z, Brey RL, Rand JH, Schneider JA, Capuano AW, Yu L, Leurgans SE, Bennett DA, Levine SR. Arvanitakis Z, et al. Among authors: brey rl. Circulation. 2015 Jan 13;131(2):182-9. doi: 10.1161/CIRCULATIONAHA.114.012479. Epub 2014 Oct 9. Circulation. 2015. PMID: 25301832 Free PMC article.

6

The role of antiphospholipid antibodies in stroke.

Coull BM, Levine SR, Brey RL. Coull BM, et al. Among authors: brey rl. Neurol Clin. 1992 Feb;10(1):125-43. Neurol Clin. 1992. PMID: 1556999 Review.

7

Risk of recurrent thromboembolic events in patients with focal cerebral ischemia and antiphospholipid antibodies. The Antiphospholipid Antibodies in Stroke Study Group.

Levine SR, Brey RL, Joseph CL, Havstad S. Levine SR, et al. Among authors: brey rl. Stroke. 1992 Feb;23(2 Suppl):I29-32. Stroke. 1992. PMID: 1561671

8

Antiphospholipid antibodies and ischemic cerebrovascular disease.

Levine SR, Brey RL. Levine SR, et al. Among authors: brey rl. Semin Neurol. 1991 Dec;11(4):329-38. doi: 10.1055/s-2008-1041238. Semin Neurol. 1991. PMID: 1811290 Review. No abstract available.

9

Treatment of neurologic complications of antiphospholipid antibody syndrome.

Brey RL, Levine SR. Brey RL, et al. Lupus. 1996 Oct;5(5):473-6. doi: 10.1177/096120339600500529. Lupus. 1996. PMID: 8902785 Review.

10

Amino terminal pro-B-type natriuretic peptide, secondary stroke prevention, and choice of antithrombotic therapy.

Longstreth WT Jr, Kronmal RA, Thompson JL, Christenson RH, Levine SR, Gross R, Brey RL, Buchsbaum R, Elkind MS, Tirschwell DL, Seliger SL, Mohr JP, deFilippi CR. Longstreth WT Jr, et al. Among authors: brey rl. Stroke. 2013 Mar;44(3):714-9. doi: 10.1161/STROKEAHA.112.675942. Epub 2013 Jan 22. Stroke. 2013. PMID: 23339958 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

97 results

Search Page